Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Analgesics, Opioid | 10 | 2024 | 591 | 1.950 |
Why?
|
| Opioid-Related Disorders | 5 | 2024 | 400 | 1.780 |
Why?
|
| Drug Overdose | 4 | 2023 | 165 | 1.520 |
Why?
|
| Opiate Substitution Treatment | 2 | 2019 | 102 | 1.100 |
Why?
|
| Drug Prescriptions | 3 | 2024 | 103 | 1.020 |
Why?
|
| Health Care Costs | 3 | 2024 | 176 | 1.000 |
Why?
|
| Abortion, Legal | 1 | 2025 | 4 | 0.960 |
Why?
|
| Abortion, Induced | 1 | 2025 | 22 | 0.950 |
Why?
|
| Urologic Surgical Procedures | 1 | 2024 | 30 | 0.880 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2024 | 52 | 0.850 |
Why?
|
| Pregnancy Outcome | 1 | 2025 | 250 | 0.840 |
Why?
|
| Pain, Postoperative | 1 | 2024 | 169 | 0.810 |
Why?
|
| Text Messaging | 1 | 2023 | 21 | 0.800 |
Why?
|
| Health Expenditures | 1 | 2023 | 74 | 0.790 |
Why?
|
| Femoral Artery | 1 | 2023 | 107 | 0.780 |
Why?
|
| Patients | 1 | 2022 | 51 | 0.770 |
Why?
|
| Peripheral Arterial Disease | 1 | 2023 | 77 | 0.770 |
Why?
|
| Registries | 2 | 2024 | 629 | 0.740 |
Why?
|
| United States | 13 | 2025 | 5227 | 0.720 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2021 | 28 | 0.690 |
Why?
|
| Legislation, Drug | 1 | 2020 | 18 | 0.690 |
Why?
|
| Antiemetics | 1 | 2020 | 32 | 0.690 |
Why?
|
| Medical Oncology | 1 | 2020 | 104 | 0.640 |
Why?
|
| Prostatic Neoplasms | 4 | 2024 | 400 | 0.640 |
Why?
|
| Criminals | 1 | 2019 | 23 | 0.600 |
Why?
|
| Veterans | 3 | 2024 | 581 | 0.600 |
Why?
|
| Retrospective Studies | 12 | 2025 | 6671 | 0.590 |
Why?
|
| Humans | 31 | 2025 | 52593 | 0.580 |
Why?
|
| Pregnant Women | 1 | 2019 | 70 | 0.570 |
Why?
|
| Serotonin Syndrome | 1 | 2018 | 5 | 0.570 |
Why?
|
| Telemedicine | 1 | 2024 | 493 | 0.560 |
Why?
|
| Benzodiazepines | 1 | 2018 | 72 | 0.550 |
Why?
|
| Patient Compliance | 1 | 2019 | 230 | 0.550 |
Why?
|
| Pregnancy Complications | 2 | 2019 | 400 | 0.550 |
Why?
|
| Phenols | 1 | 2018 | 92 | 0.530 |
Why?
|
| Antipsychotic Agents | 1 | 2018 | 235 | 0.500 |
Why?
|
| Adult | 10 | 2025 | 14170 | 0.390 |
Why?
|
| Female | 11 | 2025 | 28262 | 0.350 |
Why?
|
| Pregnancy | 3 | 2025 | 2679 | 0.320 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2023 | 266 | 0.290 |
Why?
|
| Prevalence | 2 | 2023 | 1017 | 0.280 |
Why?
|
| Chronic Pain | 2 | 2022 | 178 | 0.280 |
Why?
|
| Middle Aged | 8 | 2024 | 13096 | 0.280 |
Why?
|
| Cohort Studies | 3 | 2021 | 1553 | 0.250 |
Why?
|
| Male | 12 | 2024 | 26863 | 0.250 |
Why?
|
| State Government | 1 | 2025 | 46 | 0.240 |
Why?
|
| Time Factors | 2 | 2024 | 3000 | 0.230 |
Why?
|
| Aged | 7 | 2024 | 10191 | 0.230 |
Why?
|
| Morbidity | 1 | 2025 | 143 | 0.230 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 1686 | 0.210 |
Why?
|
| Atherectomy | 1 | 2023 | 13 | 0.210 |
Why?
|
| Patient Care | 4 | 2024 | 57 | 0.200 |
Why?
|
| Butylamines | 1 | 2023 | 2 | 0.200 |
Why?
|
| Cost-Benefit Analysis | 1 | 2024 | 269 | 0.200 |
Why?
|
| Interviews as Topic | 1 | 2024 | 274 | 0.200 |
Why?
|
| Prostate | 4 | 2024 | 117 | 0.200 |
Why?
|
| Lower Extremity | 1 | 2023 | 99 | 0.200 |
Why?
|
| Military Personnel | 1 | 2024 | 177 | 0.190 |
Why?
|
| Patient-Centered Care | 1 | 2023 | 140 | 0.190 |
Why?
|
| Osteoarthritis, Knee | 1 | 2023 | 97 | 0.190 |
Why?
|
| Decision Making | 1 | 2024 | 282 | 0.190 |
Why?
|
| Hospice Care | 1 | 2021 | 26 | 0.180 |
Why?
|
| Surgical Mesh | 1 | 2021 | 17 | 0.180 |
Why?
|
| Pharmacists | 2 | 2024 | 141 | 0.180 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2021 | 29 | 0.180 |
Why?
|
| Vagina | 1 | 2021 | 46 | 0.170 |
Why?
|
| Pilot Projects | 1 | 2023 | 721 | 0.170 |
Why?
|
| Nausea | 1 | 2020 | 46 | 0.170 |
Why?
|
| Prosthesis Failure | 1 | 2021 | 113 | 0.170 |
Why?
|
| Vomiting | 1 | 2020 | 73 | 0.170 |
Why?
|
| Stents | 1 | 2023 | 372 | 0.160 |
Why?
|
| Fentanyl | 1 | 2020 | 41 | 0.160 |
Why?
|
| Pain | 2 | 2024 | 362 | 0.160 |
Why?
|
| Evidence-Based Practice | 1 | 2020 | 111 | 0.160 |
Why?
|
| Hospices | 1 | 2019 | 11 | 0.160 |
Why?
|
| Nonprescription Drugs | 1 | 2019 | 34 | 0.160 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 300 | 0.160 |
Why?
|
| Alcoholism | 1 | 2022 | 240 | 0.160 |
Why?
|
| Pandemics | 1 | 2024 | 587 | 0.160 |
Why?
|
| SEER Program | 3 | 2024 | 103 | 0.150 |
Why?
|
| Reoperation | 1 | 2021 | 465 | 0.150 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2023 | 289 | 0.150 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2024 | 358 | 0.150 |
Why?
|
| Insurance, Health | 1 | 2019 | 133 | 0.140 |
Why?
|
| Age Distribution | 1 | 2018 | 175 | 0.140 |
Why?
|
| Infant, Newborn | 1 | 2025 | 2891 | 0.140 |
Why?
|
| Drug Interactions | 1 | 2018 | 205 | 0.140 |
Why?
|
| Risk Factors | 2 | 2023 | 3952 | 0.140 |
Why?
|
| Community Pharmacy Services | 1 | 2018 | 66 | 0.130 |
Why?
|
| Buprenorphine | 1 | 2018 | 151 | 0.130 |
Why?
|
| Odds Ratio | 1 | 2018 | 568 | 0.130 |
Why?
|
| Treatment Outcome | 2 | 2023 | 5486 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1031 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2021 | 1081 | 0.110 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 3420 | 0.110 |
Why?
|
| Patient Participation | 2 | 2024 | 69 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2018 | 428 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 1221 | 0.100 |
Why?
|
| Medicare | 2 | 2024 | 274 | 0.090 |
Why?
|
| Neoplasms | 1 | 2020 | 1308 | 0.080 |
Why?
|
| Young Adult | 1 | 2018 | 4337 | 0.070 |
Why?
|
| Adolescent | 1 | 2018 | 6737 | 0.060 |
Why?
|
| New York | 1 | 2023 | 49 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2024 | 257 | 0.050 |
Why?
|
| Psychometrics | 1 | 2024 | 230 | 0.050 |
Why?
|
| Naloxone | 1 | 2022 | 79 | 0.050 |
Why?
|
| Minority Groups | 1 | 2023 | 135 | 0.050 |
Why?
|
| Health Literacy | 1 | 2024 | 132 | 0.050 |
Why?
|
| Communication | 1 | 2023 | 257 | 0.050 |
Why?
|
| Narcotic Antagonists | 1 | 2022 | 139 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2024 | 588 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2021 | 138 | 0.040 |
Why?
|
| Administration, Cutaneous | 1 | 2020 | 53 | 0.040 |
Why?
|
| Hip Prosthesis | 1 | 2021 | 71 | 0.040 |
Why?
|
| Drug Tolerance | 1 | 2020 | 60 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 1217 | 0.040 |
Why?
|
| Gastrointestinal Agents | 1 | 2019 | 41 | 0.040 |
Why?
|
| Palliative Care | 1 | 2021 | 216 | 0.040 |
Why?
|
| Drug Utilization | 1 | 2019 | 77 | 0.040 |
Why?
|
| Sex Factors | 1 | 2021 | 729 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 524 | 0.040 |
Why?
|
| Afghan Campaign 2001- | 1 | 2018 | 40 | 0.040 |
Why?
|
| Professional Role | 1 | 2018 | 78 | 0.030 |
Why?
|
| Quality of Life | 1 | 2023 | 882 | 0.030 |
Why?
|
| Acetaminophen | 1 | 2019 | 279 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 1350 | 0.030 |
Why?
|
| Length of Stay | 1 | 2019 | 674 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 324 | 0.030 |
Why?
|